No Data
No Data
Medici (688202.SH): The repurchase period has expired and 745,200 shares have actually been repurchased
Gelonghui, May 13, 丨 Medici (688202.SH) announced that as of May 12, 2024, the company's share repurchase period has expired. The implementation of the share repurchase plan has been completed. 745,166 shares of the company's shares have been actually repurchased through the Shanghai Stock Exchange trading system, accounting for 0.5533% of the company's total share capital. The highest price of the repurchase transaction was 74.95 yuan/share. The lowest price was 34.90 yuan/share, the average repurchase price was 53.66 yuan/share, and the total amount of capital paid was RMB 53.66 per share 39,982,446.20 yuan (excluding stamp duty)
Medici (688202.SH): Accumulated cost of 378.75 million yuan to buy back 0.5136% of the shares
On May 7, GLONGHUI (688202.SH) announced that in April 2024, the company had repurchased a total of 84,412 shares of the company through centralized bidding transactions, accounting for 0.0627% of the company's total share capital. The highest price of the repurchase transaction was 35.48 yuan/share, the lowest price was 34.90 yuan/share, and the total capital paid was 2,976,090.07 yuan (excluding transaction fees such as stamp duty and transaction commissions). As of April 30, 2024, the company has repurchased a total of 691 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange trading system.
Medici (688202.SH) reported first-quarter results with a net loss of 375.5557 million yuan
Medici (688202.SH) released its report for the first quarter of 2024, achieving revenue of 260 million yuan, with...
Medici (688202.SH): The actual controller proposed that the company buy back the shares again
Gelonghui, April 23 | Medici (688202.SH) announced that it received a “Letter on Proposal to Repurchase the Company's Shares” from Mr. Chen Jinzhang, the actual controller and chairman of the company, and Mr. CHUN-LINCHEN, the actual controller, director and general manager. Mr. Chen Jinzhang and Mr. CHUN-LINCHEN proposed that the company use their own funds to buy back some of the RMB common shares already issued by the company through centralized bidding transactions through the Shanghai Stock Exchange trading system. The total amount of repurchase capital is not less than RMB 10 million, not more than RMB 2
Medici (688202.SH): Net loss of 33.21 million yuan in 2023 turned into a year-on-year loss
On April 23, GLONGHUI (688202.SH) released its 2023 annual report. Operating income was 1,366 billion yuan, down 17.68% year on year, net loss of 33.21 million yuan, which turned into loss year on year, after deducting non-net loss of 57.616 million yuan. The basic income per share was -0.26 yuan.
Medici (688202.SH): Accumulated cost of 34.899 million yuan to buy back 0.45% of shares
Gelonghui, April 1 | Medici (688202.SH) announced that as of March 31, 2024, the company had repurchased 607,326 shares of the company's shares through centralized bidding transactions. The repurchased shares accounted for 0.4510% of the company's total share capital. The highest price of the repurchase transaction was 74.95 yuan/share, the lowest price was 38.03 yuan/share, and the total amount of capital paid was RMB 34,899,240.78 (excluding transaction fees such as stamp duty and transaction fees).
No Data